Clinical trials with gene-editing tools to start: Tang Prize laureate

Chinese American biologist and 2016 Tang Prize winner in biopharmaceutical science Feng Zhang (張鋒) said Saturday that initial clinical trials using gene-editing technology to help people with genetic diseases are expected to start this year or next.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)